Serum amyloid P component enhances induction of murine amyloidosis

Laboratory Investigation

Volumn 77, Issue 5, 1997, Pages 525-531

  Togashi, Shinji ^a,f,g   Lim, Sai Kiang ^a,d,f,g   Kawano, Hiroo ^c   Ito, Sadahiro ^a   Ishihara, Tokuhiro ^b   Okada, Yoshiie ^a   Nakano, Shin ^a,f,g   Kinoshita, Toru ^a   Horie, Kyoji ^a,b,f,g   Episkopou, Vasso ^e   Gottesman, Max E ^d   Costantini, Frank ^d   Shimada, Kazunori ^c   Maeda, Shuichiro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d New York Presbyterian Columbia University Medical Center   (United States)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f National Institute   (Singapore)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM AMYLOID P;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ARTICLE; GENE MUTATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION;

ACUTE-PHASE REACTION; AMYLOIDOSIS; ANIMALS; APOLIPOPROTEINS; CELL LINE; GENE DELETION; HUMANS; KINETICS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; PROTEIN PRECURSORS; SERUM AMYLOID A PROTEIN; SERUM AMYLOID P-COMPONENT; STEM CELLS;

EID: 0030702134     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Benson MD (1995). Amyloidosis. In: Scriver CR, Beaudet AL, Sly WS, and Valle D, editors. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill, 4159-4191.
2. Breathnach SM, Melrose SM, Bhogal B, de Beer FC, Dyck RF, Tennent G, Black MM, and Pepys MB (1981). Amyloid P component is located on elastic fibre microfibrils in normal human tissue. Nature 293:652-654.
3. Cohen AS (1992). History of amyloidosis. J Intern Med 232:509-510.
4. Coria F, Castaño E, Prelli F, Larrondo-Lillo M, van Duinen S, Shelanski ML, and Frangione B (1988). Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest 58:454-458.
5. Dyck RF, Lockwood CM, Kershaw M, McHugh N, Duance VC, Baltz ML, and Pepys MB (1980). Amyloid P-component is a constituent of normal human glomerular basement membrane. J Exp Med 152:1162-1174.
6. Emsley J, White HE, O'Hara BP, Oliva G, Scinivasan N, Tickle IJ, Blundell TL, Pepys MB, and Wood SP (1994). Structure of pentameric human serum amyloid P component. Nature 367:338-345.
7. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, and Robertson EJ (1993). Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad USA 90:2375-2379.
8. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, and Zhao J (1995). Alzheimertype neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
9. Hoshii Y, Kawano H, Gondo T, Takahashi M, Ishihara T, Higuchi K, and Horiuchi S (1986). Immunohistochemical study with anti-advanced glycation end-products antibody in murine amyloidosis. Pathol Int 46:738-742.
10. Hsiao KK, Groth D, Scott M, Yang S-L, Serban H, Rapp D, Foster D, Torchia M, DeArmond SJ, and Prusiner SB (1994). Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 91:9126-9130.
11. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, and Cole G (1996). Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
12. lnoue S and Kisilevsky R (1996). A high resolution ultrastructural study of experimental murine AA amyloid. Lab Invest 74:670-683.
13. Iwanaga T, Wakasugi S, Inomoto T, Uehira M, Ohnishi S, Nishiguchi S, Araki K, Uno M, Miyazaki J, Maeda S, Shimada K, and Yamamura K (1989). Liver-specific and high-level expression of human serum amyloid P component gene in transgenic mice. Dev Genet 10:365-371.
14. Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG, and Szarek WA (1995). Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: Implications for Alzheimer's disease. Nature Med 1:143-148.
15. Kohno K, Palha JA, Miyakawa K, Saraiva MJM, Ito S, Mabuchi T, Blaner WS, Iijima H, Tsukahara S, Episkopou V, Gottesman ME, Shimada K, Takahashi K, Yamamura K, and Maeda S (1997). Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am J Pathol 150:1497-1508.
16. Meek RL, Hoffman JS, and Benditt EP (1986). Amyloidogenesis: One serum amyloid A isotype is selectively removed from the circulation. J Exp Med 163:499-510.
17. Murakami T, Yi S, Maeda S, Tashiro F, Yamamura K, Takahashi K, Shimada K, and Araki S (1992). Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Am J Pathol 141:451-456.
18. Pepys MB, Baltz M, Gomer K, Davies AJS, and Doenhoff M (1979). Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 278:259-261.
19. Pepys MB, Rademacher TW, Amatayakul-Chantler S, Williams P, Noble GE, Hutchinson WL, Hawkins PN, Nelson SR, Gallimore JR, Herbert J, Hutton T, and Dwek RA (1994). Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci USA 91:5602-5606.
20. Ram JS, DeLellis RA, and Glenner GG (1968). Amyloid III: A method for rapid induction of amyloidosis in mice, Int Arch Allergy 34:201-204.
21. Robertson EJ (1987). Embryo-derived stem cell lines. In: Robertson EJ, editor. Teratocarcinomas and embryonic stem cells: A practical approach. Oxford: IRL Press, 71-112.
22. SAS Institute Inc. (1996). The LOGISTIC procedure. In: SAS/ STAT software: Changes and enhancements through release 6.11. Cary, NC: SAS Institute Inc., 381-490.
23. Shi Z-R, Itzkowitz SH, and Kim YS (1988). A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem 36: 317-322.
24. Tashiro F, Yi S, Wakasugi S, Maeda S, Shimada K, and Yamamura K (1991). Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene. Gerontology 37(Suppl 1):56-62.
25. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, and Prusiner SB (1996). Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079-2082.
26. Tennent GA, Lovat LB, and Pepys MB (1995). Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci USA 92:4299-4303.
27. Wakasugi S, Inomoto T, Yi S, Naito M, Uehira M, Iwanaga T, Maeda S, Araki K, Miyazaki J, Takahashi K, Shimada K, and Yamamura K (1987). A transgenic mouse model of familial amyloidotic polyneuropathy. Proc Japan Acad 63(B):344 -347.
28. Yi S, Takahashi K, Naito M, Tashiro F, Wakasugi S, Maeda S, Shimada K, Yamamura K, and Araki S (1991). Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (met30) gene. Am J Pathol 138:403-412.